Journal
/
/
In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis
JoVE Journal
Medicine
Author Produced
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Medicine
In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis
DOI:

07:15 min

October 20, 2013

, , ,

Chapters

  • 00:00Title
  • 00:22Introduction
  • 02:44Induction of Septic Arthritis
  • 03:54In vivo MR Imaging
  • 05:19Significant Results
  • 06:43Conclusion

Summary

Automatic Translation

We demonstrate how to perform macrophage MR imaging using ultrasmall superparamagnetic contrast agent (USPIO) in septic arthritis, allowing an initial and longitudinal in vivo non-invasive evaluation of macrophages infiltration and an assessment of therapy efficacy.

Related Videos

Read Article